Perspective Therapeutics (CATX) had the best year in 2005 by a small-cap US stock in 2005, returning 2,416,566.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Perspective Therapeutics (CATX) | 2005 | 2,416,566.67% |
Metalla Royalty & Streaming (MTA) | 2005 | 2,642.86% |
Universal Insurance (UVE) | 2005 | 1,440.72% |
McEwen Mining (MUX) | 2005 | 741.58% |
Tanzanian Royalty Exploration (TRX) | 2005 | 597.7% |
Flotek Industries (FTK) | 2005 | 338.82% |
Cerus (CERS) | 2005 | 244.07% |
BK Technologies (BKTI) | 2005 | 236.87% |
Insperity (NSP) | 2005 | 235.14% |
Mitek Systems (MITK) | 2005 | 234.04% |
Graham (GHM) | 2005 | 203.96% |
Savara (SVRA) | 2005 | 185.22% |
BioCryst Pharmaceuticals (BCRX) | 2005 | 179.63% |
Barrett Business Services (BBSI) | 2005 | 167.75% |
PrimeEnergy (PNRG) | 2005 | 163.59% |
Columbus McKinnon (CMCO) | 2005 | 161.67% |
Citi Trends (CTRN) | 2005 | 151.86% |
PAR Technology (PAR) | 2005 | 144.8% |
RPC (RES) | 2005 | 132.5% |
Smith & Wesson Brands (SWBI) | 2005 | 124.59% |
Quidel (QDEL) | 2005 | 115.2% |
ASGN (ASGN) | 2005 | 113.92% |
Lesaka Technologies (LSAK) | 2005 | 113.7% |
Zumiez (ZUMZ) | 2005 | 110.32% |
Forward Industries (FWDI) | 2005 | 107.94% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
